Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder.

Thase ME, Stanford AD, Memisoglu A, Martin W, Claxton A, Bodkin JA, Trivedi MH, Fava M, Yu M, Pathak S.

Neuropsychopharmacology. 2019 Dec;44(13):2268-2276. doi: 10.1038/s41386-019-0451-3. Epub 2019 Jun 29.

2.

A direct comparison of mouse and human intestinal development using epithelial gene expression patterns.

Stanford AH, Gong H, Noonan M, Lewis AN, Gong Q, Lanik WE, Hsieh JJ, Lueschow SR, Frey MR, Good M, McElroy SJ.

Pediatr Res. 2019 Jun 26. doi: 10.1038/s41390-019-0472-y. [Epub ahead of print]

3.

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).

Zajecka JM, Stanford AD, Memisoglu A, Martin WF, Pathak S.

Neuropsychiatr Dis Treat. 2019 Apr 4;15:795-808. doi: 10.2147/NDT.S199245. eCollection 2019.

4.

Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study.

Correll CU, Stanford AD, Claxton A, Du Y, Weiden PJ.

Psychiatry Res. 2019 Apr;274:176-181. doi: 10.1016/j.psychres.2019.02.021. Epub 2019 Feb 14.

5.

Targeted neonatal echocardiography in the United States of America: the contemporary perspective and challenges to implementation.

Giesinger RE, Stanford AH, Rios DR, Bhombal S, Fraga MV, Levy VY, McNamara PJ; United States Hemodynamics Collaborative.

Pediatr Res. 2019 Jun;85(7):919-921. doi: 10.1038/s41390-019-0338-3. Epub 2019 Feb 18. No abstract available.

PMID:
30776791
6.

Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.

Pathak S, Vince B, Kelsh D, Setnik B, Nangia N, DiPetrillo L, Puhl MD, Sun L, Stanford AD, Ehrich E.

J Clin Pharmacol. 2019 Feb;59(2):218-228. doi: 10.1002/jcph.1343. Epub 2018 Nov 26.

PMID:
30476361
7.

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.

Fava M, Thase ME, Trivedi MH, Ehrich E, Martin WF, Memisoglu A, Nangia N, Stanford AD, Yu M, Pathak S.

Mol Psychiatry. 2018 Oct 29. doi: 10.1038/s41380-018-0284-1. [Epub ahead of print]

PMID:
30374191
8.

Reducing the impact of violence on the health status of African-Americans: Literature review and recommendations from the Society of Black Academic Surgeons.

Joseph K, Turner P, Barry L, Cooper C, Danner O, Enumah S, Hayanga JA, James I, Oppong B, Gibson CQ, Stanford A, Thomas Y, Weaver WL, Williams M, Young C, Britt LD.

Am J Surg. 2018 Sep;216(3):393-400. doi: 10.1016/j.amjsurg.2018.08.001. Epub 2018 Aug 10. Review. No abstract available.

PMID:
30143230
9.

Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia.

Nasrallah HA, Aquila R, Du Y, Stanford AD, Claxton A, Weiden PJ.

CNS Spectr. 2019 Aug;24(4):395-403. doi: 10.1017/S1092852918001104. Epub 2018 Aug 15.

PMID:
30109845
10.

Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.

Pathak S, Vince B, Kelsh D, Shram MJ, Setnik B, Lu H, Nangia N, Stanford AD, Ehrich E.

J Clin Pharmacol. 2019 Feb;59(2):206-217. doi: 10.1002/jcph.1280. Epub 2018 Aug 13.

PMID:
30102427
11.

Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period.

Weiden PJ, Du Y, Liu CC, Stanford AD.

CNS Spectr. 2019 Aug;24(4):419-425. doi: 10.1017/S1092852918000986. Epub 2018 Jun 26.

PMID:
29941057
12.

Disclosure and holding back: Communication, psychological adjustment, and marital satisfaction among couples coping with osteoarthritis.

Zhaoyang R, Martire LM, Stanford AM.

J Fam Psychol. 2018 Apr;32(3):412-418. doi: 10.1037/fam0000390.

13.

Daily Marital Tension and Symptom Severity in Older Adults With Diabetes or Osteoarthritis.

Martire LM, Hemphill RC, Zhaoyang R, Stephens MAP, Franks MM, Stanford AM.

Ann Behav Med. 2018 Sep 13;52(10):842-853. doi: 10.1093/abm/kax062.

14.

Long-range gamma phase synchronization as a compensatory strategy during working memory in high-performing patients with schizophrenia.

So RP, Kegeles LS, Mao X, Shungu DC, Stanford AD, Chen CA.

J Clin Exp Neuropsychol. 2018 Sep;40(7):663-681. doi: 10.1080/13803395.2017.1420142. Epub 2018 Feb 1.

PMID:
29388507
15.

Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.

McEvoy JP, Risinger R, Mykhnyak S, Du Y, Liu CC, Stanford AD, Weiden PJ.

J Clin Psychiatry. 2017 Sep/Oct;78(8):1103-1109. doi: 10.4088/JCP.17m11625.

16.

Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil.

Nasrallah HA, Aquila R, Stanford AD, Jamal HH, Weiden PJ, Risinger R.

Psychopharmacol Bull. 2017 Aug 1;47(3):35-43.

17.

It's unfair to push your beliefs.

Stanford A.

Nurs Stand. 2017 May 31;31(40):32. doi: 10.7748/ns.31.40.32.s30.

PMID:
28558587
18.

Using diffusion tensor imaging to identify corticospinal tract projection patterns in children with unilateral spastic cerebral palsy.

Kuo HC, Ferre CL, Carmel JB, Gowatsky JL, Stanford AD, Rowny SB, Lisanby SH, Gordon AM, Friel KM.

Dev Med Child Neurol. 2017 Jan;59(1):65-71. doi: 10.1111/dmcn.13192. Epub 2016 Jul 27.

19.

Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012.

Wu B, Bell K, Stanford A, Kern DM, Tunceli O, Vupputuri S, Kalsekar I, Willey V.

BMJ Open Diabetes Res Care. 2016 Apr 11;4(1):e000154. doi: 10.1136/bmjdrc-2015-000154. eCollection 2016.

20.

Skilled Bimanual Training Drives Motor Cortex Plasticity in Children With Unilateral Cerebral Palsy.

Friel KM, Kuo HC, Fuller J, Ferre CL, Brandão M, Carmel JB, Bleyenheuft Y, Gowatsky JL, Stanford AD, Rowny SB, Luber B, Bassi B, Murphy DL, Lisanby SH, Gordon AM.

Neurorehabil Neural Repair. 2016 Oct;30(9):834-44. doi: 10.1177/1545968315625838. Epub 2016 Feb 11.

21.

Postglacial expansion pathways of red mangrove, Rhizophora mangle, in the Caribbean Basin and Florida.

Kennedy JP, Pil MW, Proffitt CE, Boeger WA, Stanford AM, Devlin DJ.

Am J Bot. 2016 Feb;103(2):260-76. doi: 10.3732/ajb.1500183. Epub 2016 Feb 2.

22.

Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

Cieslak K, Walsh-Messinger J, Stanford A, Vaez-Azizi L, Antonius D, Harkavy-Friedman J, Goetz D, Goetz RR, Malaspina D.

J Psychiatry Neurosci. 2015 Nov;40(6):387-93.

23.

GABA level, gamma oscillation, and working memory performance in schizophrenia.

Chen CM, Stanford AD, Mao X, Abi-Dargham A, Shungu DC, Lisanby SH, Schroeder CE, Kegeles LS.

Neuroimage Clin. 2014 Mar 20;4:531-9. doi: 10.1016/j.nicl.2014.03.007. eCollection 2014.

24.

Deep brain stimulation and ablation for obsessive compulsive disorder: evolution of contemporary indications, targets and techniques.

Tierney TS, Abd-El-Barr MM, Stanford AD, Foote KD, Okun MS.

Int J Neurosci. 2014 Jun;124(6):394-402. doi: 10.3109/00207454.2013.852086. Epub 2013 Nov 8. Review.

PMID:
24099662
25.

Single pulse TMS differentially modulates reward behavior.

Stanford AD, Luber B, Unger L, Cycowicz YM, Malaspina D, Lisanby SH.

Neuropsychologia. 2013 Dec;51(14):3041-7. doi: 10.1016/j.neuropsychologia.2013.09.016. Epub 2013 Sep 14.

PMID:
24041669
26.

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC.

Arch Gen Psychiatry. 2012 May;69(5):449-59. doi: 10.1001/archgenpsychiatry.2011.1519. Epub 2012 Jan 2.

PMID:
22213769
27.

Theory of Mind in patients at clinical high risk for psychosis.

Stanford AD, Messinger J, Malaspina D, Corcoran CM.

Schizophr Res. 2011 Sep;131(1-3):11-7. doi: 10.1016/j.schres.2011.06.005. Epub 2011 Jul 14.

28.

High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series.

Stanford AD, Corcoran C, Bulow P, Bellovin-Weiss S, Malaspina D, Lisanby SH.

J ECT. 2011 Mar;27(1):11-7. doi: 10.1097/YCT.0b013e3181f41ea3.

29.

Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Messinger JW, Trémeau F, Antonius D, Mendelsohn E, Prudent V, Stanford AD, Malaspina D.

Clin Psychol Rev. 2011 Feb;31(1):161-8. doi: 10.1016/j.cpr.2010.09.002. Epub 2010 Sep 18. Review.

30.

Self-specific processing in the default network: a single-pulse TMS study.

Lou HC, Luber B, Stanford A, Lisanby SH.

Exp Brain Res. 2010 Nov;207(1-2):27-38. doi: 10.1007/s00221-010-2425-x. Epub 2010 Sep 29.

31.

The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis.

Corcoran CM, Kimhy D, Parrilla-Escobar MA, Cressman VL, Stanford AD, Thompson J, David SB, Crumbley A, Schobel S, Moore H, Malaspina D.

Psychol Med. 2011 Feb;41(2):251-61. doi: 10.1017/S0033291710000802. Epub 2010 May 6.

32.

Later paternal age and sex differences in schizophrenia symptoms.

Rosenfield PJ, Kleinhaus K, Opler M, Perrin M, Learned N, Goetz R, Stanford A, Messinger J, Harkavy-Friedman J, Malaspina D.

Schizophr Res. 2010 Feb;116(2-3):191-5. doi: 10.1016/j.schres.2009.10.020. Epub 2009 Nov 17.

33.

Family history of affective illness in schizophrenia patients: symptoms and cognition.

Anglin D, Stanford AD, Harkavy-Friedman JM, Goetz R, Rosenfield P, Malaspina D.

Schizophr Res. 2009 May;110(1-3):24-7. doi: 10.1016/j.schres.2009.02.020. Epub 2009 Mar 21.

34.

Implementation of Mexico's Health Promotion Operational Model.

Santos-Burgoa C, Rodríguez-Cabrera L, Rivero L, Ochoa J, Stanford A, Latinovic L, Rueda G.

Prev Chronic Dis. 2009 Jan;6(1):A32. Epub 2008 Dec 15.

35.

Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.

Corcoran CM, Kimhy D, Stanford A, Khan S, Walsh J, Thompson J, Schobel S, Harkavy-Friedman J, Goetz R, Colibazzi T, Cressman V, Malaspina D.

Schizophr Res. 2008 Dec;106(2-3):286-93. doi: 10.1016/j.schres.2008.08.008. Epub 2008 Sep 21.

36.

rTMS strategies for the study and treatment of schizophrenia: a review.

Stanford AD, Sharif Z, Corcoran C, Urban N, Malaspina D, Lisanby SH.

Int J Neuropsychopharmacol. 2008 Jun;11(4):563-76. doi: 10.1017/S1461145707008309. Epub 2008 Feb 1. Review.

37.

Remediation of sleep-deprivation-induced working memory impairment with fMRI-guided transcranial magnetic stimulation.

Luber B, Stanford AD, Bulow P, Nguyen T, Rakitin BC, Habeck C, Basner R, Stern Y, Lisanby SH.

Cereb Cortex. 2008 Sep;18(9):2077-85. doi: 10.1093/cercor/bhm231. Epub 2008 Jan 17.

38.

Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS).

Goetz RR, Corcoran C, Yale S, Stanford AD, Kimhy D, Amador X, Malaspina D.

Schizophr Res. 2007 Jul;93(1-3):169-77. Epub 2007 Apr 12.

39.

Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation.

Luber B, Stanford AD, Malaspina D, Lisanby SH.

Biol Psychiatry. 2007 Oct 1;62(7):793-9. Epub 2007 Jan 17.

40.

Where love flies free: women, home, and writing in Cook County Jail.

Stanford AF.

J Prev Interv Community. 2005;30(1-2):49-56.

PMID:
16556589
41.

Odor identification impairments in schizophrenia: relationship with demographic measures, clinical variables, and diagnostic subtypes.

Coleman E, Goetz RR, Leitman D, Yale S, Stanford A, Gorman JM, Malaspina D.

CNS Spectr. 2002 Jan;7(1):43-8.

PMID:
15254448
42.

Trail making and olfaction in schizophrenia: implications for processing speed.

Goudsmit N, Wolitzky R, Seckinger RA, Corcoran C, Stanford A, Rosenfield P, Goetz R, Malaspina D.

CNS Spectr. 2004 May;9(5):344-9, 356.

PMID:
15115946
43.

A brief smell identification test discriminates between deficit and non-deficit schizophrenia.

Goudsmit N, Coleman E, Seckinger RA, Wolitzky R, Stanford AD, Corcoran C, Goetz RR, Malaspina D.

Psychiatry Res. 2003 Sep 30;120(2):155-64.

PMID:
14527647
44.

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry.

Parnes C, Guillermin J, Habersang R, Nicholes P, Chawla V, Kelly T, Fishbein J, McRae P, Goessler M, Gatti A, Calcagno JA, Eki C, Harris KA, Joyave J, McFarland K, Protter P, Sullivan M, Stanford A, Lovett N, Ortiz M, Rojas S, Cyrus S, Cyrus J, Cohen S, Buchin D, Riordan L, Zuniga M, Shah R, Minard C, Quintin A, Douglas G, van Houten J, Freutner S, Chartrand S, Nowatzke P, Romero J, Rhodes T, Benoit M, Walter E, Walker L, DeBonnett L, Cross M, Free T, Martin S, Shank K, Guedes B, Atkinson LA, Halpin GJ, Rouse K, Hand I, Geiss D, Marshall JR, Burleson L, Boland J, Seybold K, Hunter V, Unfer S, Schmucker J, Gley M, Marcus M, Thompson P, Milla P, Young C, Zanni R, Zinno V, Fetter-Zarzeka A, Busey A, Sokunbi MA, Airington S, Richard N, Muraligopal V, Lewis S, Weber FT, Giordano BP, Linehan D, Roach J, Davis R, Rzepka AA, Booth T, Smeltzer D, Walsh J, Arispe E, Rowley R, Bolling C, Botts T, Haskett K, Raby D, Batiz E, Gelfand A, Farrell L, Butler S, Colby L, Schochet P, Bentler J, Hirsch D, Wilkinson L, Aaronson A, Bennett E, Wingate J, Quinn D, Komendowski K, Deckard M, Frogel M, Nerwen C, Copenhaver S, Prater M, Wolsztein J, Mackey K, Benbow M, Naranjo M, Hensley S, Hayes C, Sadeghi H, Lawson SM, McCall M, Combs K, Ledbetter J, Sarnosky K, Swafford C, Speer M, Barton WJ, Mink JW, Lemm D, Hudak M, Case E, Rowen J, Fuentes S, Pane C, Richardson L, Chavarria C, Cassino D, Ghaffari K, Carroll C, Lee H, Guclu L, Johnson C, Blum V, Boron ML, Sorrentino M, Hirsch RL, Van Veldhuisen PC, Smith C; Palivizumab Outcomes Registry Study Group.

Pediatr Pulmonol. 2003 Jun;35(6):484-9.

PMID:
12746948
45.

Laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents.

Stanford A, Glascock JM, Eid GM, Kane T, Ford HR, Ikramuddin S, Schauer P.

J Pediatr Surg. 2003 Mar;38(3):430-3. Review.

PMID:
12632362
46.

The clock drawing test is a poor screen for very mild dementia.

Powlishta KK, Von Dras DD, Stanford A, Carr DB, Tsering C, Miller JP, Morris JC.

Neurology. 2002 Sep 24;59(6):898-903.

PMID:
12297574
47.

Long-term follow-up of patients with necrotizing enterocolitis.

Stanford A, Upperman JS, Boyle P, Schall L, Ojimba JI, Ford HR.

J Pediatr Surg. 2002 Jul;37(7):1048-1050; discussion 1048-1050.

PMID:
12077769
48.

Surgical management of open versus laparoscopic adrenalectomy: outcome analysis.

Stanford A, Upperman JS, Nguyen N, Barksdale E Jr, Wiener ES.

J Pediatr Surg. 2002 Jul;37(7):1027-9.

PMID:
12077764
49.

The surgical management of short bowel syndrome.

Barksdale EM, Stanford A.

Curr Gastroenterol Rep. 2002 Jun;4(3):229-37. Review.

PMID:
12010624
50.

Supplemental Content

Loading ...
Support Center